ReWalk Robotics Ltd. (RWLK) Surges to 1 Year Low, Is Now Worst Performer

May 16, 2018 - By Catherine Nunes

ReWalk Robotics Ltd. (NASDAQ:RWLK) Logo

The stock of ReWalk Robotics Ltd. (NASDAQ:RWLK) hit a new 52-week low and has $1.04 target or 4.00 % below today’s $1.08 share price. The 6 months bearish chart indicates high risk for the $32.26 million company. The 1-year low was reported on May, 16 by If the $1.04 price target is reached, the company will be worth $1.29M less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock.

It closed at $1.08 lastly. It is up 48.78% since May 16, 2017 and is downtrending. It has underperformed by 60.33% the S&P500.

ReWalk Robotics Ltd. (NASDAQ:RWLK) Ratings Coverage

Among 2 analysts covering Rewalk Robotics (NASDAQ:RWLK), 1 have Buy rating, 1 Sell and 0 Hold. Therefore 50% are positive. Rewalk Robotics had 2 analyst reports since January 7, 2018 according to SRatingsIntel. The stock of ReWalk Robotics Ltd. (NASDAQ:RWLK) has “Buy” rating given on Sunday, January 7 by Piper Jaffray.

More important recent ReWalk Robotics Ltd. (NASDAQ:RWLK) news were published by: which released: “ReWalk Robotics to Report First Quarter 2018 Financial Results on May 10, 2018” on May 09, 2018, also published article titled: “ReWalk Robotics’ (RWLK) CEO Larry Jasinski on Q1 2018 Results – Earnings Call Transcript”, published: “ReWalk Robotics Reports First Quarter 2018 Financial Results” on May 10, 2018. More interesting news about ReWalk Robotics Ltd. (NASDAQ:RWLK) was released by: and their article: “ReWalk Robotics Receives First Tranche of $5 Million as Part of $20 Million Strategic Investment from Timwell …” with publication date: May 15, 2018.

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company has market cap of $32.26 million. The firm offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. It currently has negative earnings. ReWalk Robotics Ltd. markets and sells its products directly to institutions and individuals, as well as through third-party distributors.

ReWalk Robotics Ltd. (NASDAQ:RWLK) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.